News
Stocktwits on MSN2h
Channel Therapeutics Stock Soars On Announcement Of Subsidiary’s Merger With Ligand Pharma Units: Retail’s ElatedShares of Channel Therapeutics Corporation (CHRO) rocketed 61% on Thursday after the company entered into a definitive merger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback